Furthermore, the ex vivo tumor sections analysis showed that the protein levels of Bax, Bcl-2, GRP-94, and calpain I increased (~1.2 to 3.01 fold) or decreased (~0.55 to 0.04 fold) significantly in the ACDB-stimulated group than the control group (Figure 6E). The gene discussed is BCL2; the disease is neoplasm.